Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats

Molecular Nutrition and Food Research

Volumn 49, Issue 5, 2005, Pages 482-494

  Wenzel, Elisabeth ^a   Soldo, Tomislav ^a   Erbersdobler, Helmut ^b   Somoza, Veronika ^a  

^a DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemoprevention; Metabolism; Resveratrol; Resveratrol glucuronide; Resveratrol sulfate

Indexed keywords

DRUG METABOLITE; ENZYME; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEEDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KIDNEY; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; ERYTHROCYTES; FECES; GLUCURONIDES; GLUTATHIONE TRANSFERASE; KIDNEY; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RATS, WISTAR; STILBENES; SULFATES;

ANIMALIA; RATTUS NORVEGICUS;

EID: 20344371723     PISSN: 16134125     EISSN: None     Source Type: Journal    
DOI: 10.1002/mnfr.200500003     Document Type: Article

References (39)

1. Burns, J., Yokota, T., Ashihara, H., Lean, M. E., Crozier, A., Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002, 50, 3337-3340.
2. Ribeiro de Lima, M. T., Waffo-Teguo, P., Teissedre, P. L., Pujolas, A., et al., Determination of stilbenes in Portuguese wines. J. Agric. Food Chem. 1999, 47, 2666-2670.
3. Wang, Y., Catana, F., Yang, Y., Roderick, R., van Breemen, R. B., An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J. Agric. Food Chem. 2002, 50, 431-435.
4. Frémont, L., Minireview: biological effects of resveratrol. Life Sci. 1999, 66, 663-673.
5. Bhat, K. P. L., Kosmeder II, J. W., Pezzuto J. M., Biological effects of resveratrol. Antioxid. Redox. Signal. 2001, 3, 1041-1064.
6. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
7. Gescher, A. J., Steward, W. P., Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev. 2003, 12, 953-957.
8. Aziz, M. H., Kumar, R., Ahmad, N., Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the unterlying mechanisms (Review). Int. J. Oncol. 2003, 23, 17-28.
9. Savouret, J. F., Quesne, M., Resveratrol and cancer: a review. Biomed. Pharmacother. 2002, 56, 84-87.
10. Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., et al., Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Comm. 2000, 272, 212-217.
11. Andlauer, W., Kolb, J., Siebert, K., Fürst, P., Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs. Exptl. Clin. Res. 2000, XXVI, 47-55.
12. Marier, J. F., Vachon, P., Gritsas, A., Zhang, J., et al., Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 2002, 302, 369-373.
13. Yu, C., Shin, Y. G., Chow, A., Li, Y., et al., Human, rat and mouse metabolism of resveratrol. Pharm. Res. 2002, 19, 1907-1914.
14. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003, 72, 2219-2233.
15. Goldberg, D. M., Yan, J., Soleas, G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subujects. Clin. Biochem. 2003, 36, 79-87.
16. Meng, X., Maliakal, P., Lu, H., Lee, M. J., Yang, C. S., Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 2004, 52, 935-942.
17. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Walle, U. K., High absorption but very low bioavailability of oral resveratrol in humans. Drug. Metab. Dispos. 2004, 32, 1377-1382.
18. Learmonth, D. A., A concise synthesis of the 3-O-β-d- and 4′-O-β-d-glucuronide conjugates of trans-resveratrol. Bioconj. Biochem. 2003, 14, 262-267.
19. Wenzel, E., Tasto, S., Erbersdobler, H. F., Faist, V., Effect of heat treated proteins on selected parameters of the biotransformation system in the rat. Ann. Nutr. Metab. 2002, 46, 9-16.
20. Masters, B. S. S., Williams, C. H., Konnin, H., The preparation and properties of microsomal TPNH cytochrome c reductase from pig liver, in: Eastabroook, R. W., Pullman, M. E. (Eds.), Methods in Enzymology, Vol. 10, Academic Press, New York, 1967.
21. Habig, W. H., Pabst, M. J., Jakoby, W. B., Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
23. Markwell, M. K., Hoas, S. M., Bieber, L. L., Tobert, N. E., A modification of the Lowry procedure to simplify protein determination in membranes and lipoprotein samples. Anal. Biochem. 1978, 87, 206-210.
24. Lindenmeier, M., Faist, V., Hofmann, T., Pronylation of proteins - a novel protein modification in bread crust showing in vitro antioxidative and phase I/II-enzyme modulating activity. J. Agric. Food Chem. 2002, 50, 6997-7006.
25. Jakob, E., Elmadfa, I., Rapid HPLC assay for the assessment of vitamin K1, A, E and β-carotene status in children (7-19 years). Int. J. Vit. Nutr. Res. 1995, 65, 31-35.
26. Zoellner, N., Kirsch, K., Column chromatographic separation of plasma lipids. I. Methods and identification of the fractions. Z. Ges. Exp. Med. 1960, 134, 10-28.
27. Kawai, N., Fujibayashi, Y., Kuwabara, S., Takao, K.-I., et al., Synthesis of a potential key intermediate of Akaterpin, specific inhibitor of PI-PLC. Tetrahedron 2000, 56, 6467-6478.
28. Brandolini, V., Maietti, A., Tedeschi, P., Durini, E., et al., Capillary electrophoresis determination, synthesis, and stability of resveratrol and related 3-O-β-D-glucopyranosides. J. Agric. Food Chem. 2002, 50, 7407-7411.
29. Soleas, G. J., Angelini, M., Grass, L., Diamandis, E. P., Goldberg, D. M., Absorption of trans-resveratrol in rats. Methods Enzymol. 2001, 335, 145-154.
30. Bertelli, A. A. E., Giovannini, L., Stradi, R., Urien, S., et al., Kinetics of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration to rats. Int. J. Clin. Pharm. Res. 1996, 16, 77-81.
31. Breinholt, V. M., Molck, A. M., Svendsen, G. W., Daneshvar, B., et al., Effects of dietary antioxidants and 2-amino-3-methylimidazo[4.5-f]-quinoline (IQ) on preneoplastic lesions and on oxidative damage, hormonal status, and detoxification capacity in the rat. Food Chem. Toxicol. 2003, 41, 1315-1323.
32. Crowell, J. A., Korytko, P. J., Morrissey, R. L., Booth, T. D., Levine, B. S., Resveratrol-associated renal toxicity. Toxicol. Sci. 2004, 82, 614-619.
33. Yen, G. C., Duh, P. D., Lin, C. W., Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic. Res. 2003, 37, 509-514.
34. Asensi, M., Medina, I., Ortega, A., Carretero, J., et al., Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 2002, 33, 387-398.
35. Bertelli, A. A. E., Giovannini, L., Stradi, R., Bertelli, A., Tillement, J. P., Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short term or prolonged administration of red wine to rats. Int. J. Tiss. Reac. 1996, 18, 67-71.
36. de Santi, C., Pietrabissa, A., Mosca, F., Pacifici, G. M., Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 2000, 30, 1047-1054.
37. Juan, M. E., Lamuela-Raventós, R. M., de la Torre-Boronat, M. C., Planas, J. M., Determination of trans-resveratrol in plasma by HPLC. Anal. Chem. 1999, 71, 747-750.
38. Sale, S., Verschoyle, R. D., Boocock, D., Jones, D. J. L., et al., Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans-3,4,5,4′-tetramethoxystilbene. Br. J. Cancer 2004, 90, 736-744.
39. Rimbach, G., Weinberg, P. D., de Pascual-Teresa, S., Alonso, M. G., et al., Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochim. Biophys. Acta 2004, 1670, 229-237.